Advances in FGFR Inhibition for Bladder Cancer: A Review of Molecular Targets and Therapeutic Progress

Current Pharmacogenomics and Personalized Medicine · Published 2026-07-17 · DOI 10.2174/0118756921464978260708080238

Authors (5)

Nandita Yadav, Nihar Ranjan Sarmah, Ketan J. Purohit, Ajay Shelke, Archana Navale

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Yadav, N., Sarmah, N., Purohit, K., et al. (2026). Advances in FGFR Inhibition for Bladder Cancer: A Review of Molecular Targets and Therapeutic Progress. Current Pharmacogenomics and Personalized Medicine. https://doi.org/10.2174/0118756921464978260708080238

Related articles